Article thumbnail

Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analyses

By Shu-Yi Yin, Wen-Hsin Wang, Bi-Xue Wang, Kandan Aravindaram, Pei-Ing Hwang, Han-Ming Wu and Ning-Sun Yang
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1999). A: The role of chemokines in the regulation of dendritic cell trafficking.
  2. (1997). Allison JP: The emerging role of CTLA-4 as an immune attenuator. Immunity
  3. (2002). Annexins: From Structure to Function. Physiol Rev
  4. (1999). Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med
  5. (1999). Chemical, analysis and immunological investigations of Echinacea phytopharmaceuticals. Immunomodulatory Agents from Plants
  6. (1998). Chemokines-chemotactic cytokines that mediate inflammation.
  7. (2009). Cunnick JE: Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation.
  8. (1998). Dendritic cells and the control of immunity. Nature
  9. (2002). DY: Characterisation of human and mouse peroxiredoxin IV: evidence of inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species. Antioxid Redox Signal
  10. (1996). EL: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol
  11. (2006). et al: The transcriptional landscape of the mammalian genome. Science
  12. (2007). Evaluation of Echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis
  13. (1996). Falo LD: Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
  14. (1997). Farese RVJ: Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in CC chemokine receptor 2 knockout mice.
  15. (1997). Hughes BG: Echinaceainduced cytokine production by human macrophages.
  16. (1997). Human Chemokines: an update. Annu Rev Immunol
  17. (1992). Identification of proliferating dendritic cell precursors in mouse blood.
  18. (2000). IF: A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses.
  19. (1998). Immunologic in vivo and in vitro examinations of Echinacea extracts. Arzneim Forsch
  20. (2005). Immunotherapy via dendritic cells. Adv Exp Med Biol
  21. (1992). Knick E: Enhancement of resistance in common cold by Echinacea purpurea. Z Phytother
  22. (1997). Langerhans’ cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology
  23. (2005). LJ: Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin-4 and lipopolysaccharide. Proteomics
  24. (1991). LohmannMatthes ML: Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system.
  25. (1998). Molecular basis of T cell inactivation by CTLA-4. Science
  26. (2008). NS: Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells.
  27. (2004). Overcoming Self: A company tries to turn the immune system against cancer. Scientific American
  28. (2002). Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol
  29. (2002). PL: Cancer vaccines and immunotherapy. Br Med Bull
  30. (2000). Proteomics to study genes and genomes. Nature
  31. (2001). Renno T: Cancer vaccine design: A novel bacterial adjuvant for peptide-specific CTL induction.
  32. (2008). RP: Echinacea alkylamides modulate induced immune responses in T-cells. Fitoterapia
  33. (2003). RR: Angiomotin regulates visceral endoderm movements during mouse embryogenesis. Current Biology
  34. (2002). Schmidt-Wolf IG: Generation of dendritic cell-based vaccines for cancer therapy.
  35. (2005). SF: A network-based analysis of systemic inflammation in humans. Nature
  36. (2002). Shyur LF: Profiling and characterization of antioxidant activities in Anoectochilus formosanus Hayata. J Agric Food Chem
  37. (2006). SL: Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther
  38. (1997). Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo.
  39. The risk-benefit profile of commonly used herbal therapies.
  40. (2002). TK: Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. Int Immunopharmacol
  41. (1993). Udey MC: Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature
  42. (1998). Udey MC: Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo.
  43. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Nat Med
  44. (2006). Yang NS: Modulatory effects of Echinacea purpurea extracts on human dendritic cells: A cell- and gene-based study. Genomics